Streetbeat News

Regulatory

DYN

Dyne Therapeutics, Inc. (NASDAQ:DYN) announced its participation in the 2024 Muscular Dystrophy Association Clinical & Scientific Conference with two presentations on initial clinical data from its ACHIEVE and DELIVER trials in DM1 and DMD patients, respectively. The data, first reported in January 2024, demonstrated proof-of-concept for its DM1 and DMD programs, validating the FORCE platform's targeted delivery to muscle. Additional data from these trials is expected in the second half of 2024. The ACHIEVE trial evaluates DYNE-101 in DM1 patients, while the DELIVER trial assesses DYNE-251 in DMD patients amenable to exon 51 skipping. Both trials have shown promising initial results and safety data.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 10:09 pm

KAVL

Kaival Brands Innovations Group, Inc. (KAVL), the exclusive U.S. distributor for Bidi Vapor, reported a revenue increase to $13.1M for the fiscal year ending October 31, 2023, up from $12.8M the previous year. The company highlighted operational improvements, a focus on cost management, and strategic initiatives aimed at diversifying revenue streams and enhancing shareholder value. Despite facing regulatory challenges, Kaival Brands is optimistic about its long-term investment thesis and is actively pursuing new revenue opportunities, including leveraging a patent portfolio acquired from GoFire Inc. in May 2023.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:59 pm

CENN

Cenntro Electric Group Limited (NASDAQ:CENN) has announced the adjournment of its second court hearing for the scheme of arrangement to re-domicile from Australia to the U.S. The hearing is now scheduled for February 16, 2024. This adjournment allows Cenntro to prepare further evidence regarding shareholder voting on the scheme. The scheme, subject to court approval, aims for Cenntro to become a subsidiary of Cenntro Inc., incorporated in Nevada. The updated timetable indicates the scheme's implementation by February 27, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:55 pm

NUZE

NuZee, Inc. has announced an extension for the filing of its Form 10-Q. This delay in filing may indicate potential issues in financial reporting or operational challenges the company is facing. Investors should monitor the situation closely as further delays or disclosures of financial discrepancies could impact the company's stock price negatively in the short term.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:44 pm

QMCO

Quantum Corporation (NASDAQ:QMCO) announced a delay in filing its Form 10-Q for Q4 2023 due to re-evaluating its application of Standalone Selling Price under ASC Topic 606. This has led to non-compliance with Nasdaq Listing Rule 5250(c)(1), receiving a notice from Nasdaq. Quantum aims to complete its assessment by March 31, 2024, and has disclosed unaudited cash and debt balances as of December 31, 2023.

Portfolio Pulse from Happy Mohamed

February 14, 2024 | 9:42 pm

SGHT

Sight Sciences, Inc. (NASDAQ:SGHT) announced the European launch of the Ergo-Series of the OMNI Surgical System at the ESCRS Winter Meeting. The system, designed for minimally invasive glaucoma procedures, has been well received in the U.S. for its ergonomic design and precise cannula tip. The launch follows the receipt of the CE Mark under the new EU Medical Device Regulation, indicating a positive outlook for its adoption in Europe.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:37 pm

GDHG

Golden Heaven Group Holdings Ltd. (GDHG), a China-based amusement park operator, received a Nasdaq notification for not meeting the minimum bid price requirement. The company's shares fell below the $1.00 threshold for 30 consecutive days. Nasdaq has given GDHG until August 6, 2024, to regain compliance, potentially through measures like a reverse share split. The notification does not currently affect GDHG's listing or operations.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:27 pm

NXU

Nxu announced it has fully regained compliance with Nasdaq's continued listing requirements, ensuring its continued presence on the exchange.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:01 pm

QQQ

SPY

Bluford Putnam, former chief economist at CME Group, downplayed the significance of the January inflation numbers, suggesting the market overreacted to a slight month-over-month increase. He believes the Federal Reserve will delay rate cuts until at least June or July, emphasizing the importance of a cautious approach to avoid reigniting inflation. The S&P 500 and NASDAQ, along with ETFs SPY and QQQ, experienced declines following the inflation report. Putnam also highlighted the potential risks facing regional banks with significant exposure to commercial real estate loans.

Portfolio Pulse from Neil Dennis

February 14, 2024 | 7:31 pm

QQQ

SPY

Treasury Secretary Janet Yellen emphasized the importance of focusing on the long-term inflation trend, stating inflation is 'moving decisively down' despite a recent report showing a rise in January's inflation figures. The S&P 500 and Nasdaq experienced significant sell-offs following the report but saw partial recoveries the next day. Yellen highlighted improvements in the economy, including lower gas prices, declining prices for eggs and cars, and wage increases, particularly for lower-income workers. She also discussed the U.S. economy's resilience compared to other advanced economies and the focus on supporting middle-class families and investments in clean energy.

Portfolio Pulse from Dustin Blitchok

February 14, 2024 | 7:01 pm